Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001
Maladaptive Pulmonary vascular responses to chronic intermittent and sustained hypoxia in a rat hypertension model Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018
Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans Source: Eur Respir J 2005; 25: 173-180 Year: 2005
Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics Source: Eur Respir J 2012; 40: 1401-1409 Year: 2012
Systemic inflammation and vascular dysfunction in patients with OSA Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006
Actions of acute and chronic hypoxia on oxygen-sensing pulmonary vascular fibroblasts Source: Annual Congress 2004 - Chronic tissue hypoxia and gene expression: a systems approach to adaptation Year: 2004
Role of intermittent or continuous hypoxia in systemic inflammation measured by echography Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats Source: Eur Respir J 2010; 35: 584-591 Year: 2010
Carbamylated erythropoietin prevents cardio-respiratory dysfunctions induced by chronic intermittent hypoxia Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018
Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia Source: Eur Respir J 2012; 39: 1492-1500 Year: 2012
Oxygen therapy decreases systemic inflammation in patients with chronic obstructive pulmonary disease and hypoxemia Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010
Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011
The effect of acetazolamide on pulmonary hypertension induced by chronic hypoxia in rats Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008
Abnormal systemic cytokine response to a progressive inspiratory loading test in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 87s Year: 2003
Prevalence and contributing factors for daytime and nocturnal hypoxia in chronic heart failure patients Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017
Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4) 1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017